Bicycle Therapeutics Plc (BCYC)
4.84
-0.01
(-0.21%)
USD |
NASDAQ |
Apr 24, 16:00
4.845
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics Profit Margin (Quarterly) : -42.03% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -- |
| NuCana Plc | -- |
| DBV Technologies SA | -- |
| Cellectis SA | -253.1% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -32.03% |
| Return on Assets | -26.45% |
| Return on Invested Capital | -31.56% |
| Gross Profit Margin (Quarterly) | 97.21% |
| Operating Margin (Quarterly) | -64.90% |
| Return on Net Operating Assets | -1.37K% |